Description

CJC-1295 without DAC is a modified GHRH analog designed to stimulate the natural release of growth hormone. The “without DAC” version has a shorter duration of action than the DAC-modified form, making it a subject of research into pulsatile hormone release.

Ipamorelin (IPA) is a selective growth hormone secretagogue that has been studied for its ability to promote growth hormone release while having minimal effects on other hormones in preclinical research.

Together, this peptide combination is commonly investigated for its potential roles in:

• Growth hormone secretion research
• Recovery and tissue repair studies
• Lean body composition research
• Muscle and connective tissue studies
• Sleep and metabolic function research